SILA 421, an inhibitor of efflux pumps of cancer cells, enhances the killing of intracellular extensively drug-resistant tuberculosis (XDR-TB)

Research output: Contribution to journalArticle

31 Citations (Scopus)

Fingerprint Dive into the research topics of 'SILA 421, an inhibitor of efflux pumps of cancer cells, enhances the killing of intracellular extensively drug-resistant tuberculosis (XDR-TB)'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences